Genetic Technologies Executes Settlement and License Agreement

In compliance with ASX Continuing Disclosure Rules, Genetic Technologies Limited GENE is pleased to report that it has executed a of Longmont, Colorado, USA. Under the Agreement, Eurofins STA is granted non-exclusive rights to a number of GTG patents relating to its non-coding DNA technology. As with other similar agreements, the precise commercial terms of the Agreement are covered by formal confidentiality provisions and cannot be disclosed.